Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Nearly 90% Of Japanese Physicians Want 14-day Dispensing Rule Changed, PhRMA Says

This article was originally published in PharmAsia News

Executive Summary

TOKYO - As many as 88 percent of physicians and medical practitioner facilities want the 14-day rule that applies to newly listed drugs to be repealed or relaxed, according to a Pharmaceutical Research and Manufacturers of America report released Feb. 25

You may also be interested in...



Japan Unlikely To Relax Dispensing Limits On New Drugs

TOKYO - Even though Japan relaxed prescription drug-dispensing periods in 2002, it continues to limit dispensing for narcotics and for new drugs during the first year of launch - a regulation the U.S. believes is a barrier to trade that inconveniences patients and doctors

PharmAsia News Business Bulletin

A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).

PharmAsia News Business Bulletin

A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).

Latest Headlines
See All
UsernamePublicRestriction

Register

SC074148

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel